Clinical activity of fulvestrant in metastatic breast cancer previously treated with endocrine therapy and/or chemotherapy

BACKGROUND/AIMS: We conducted a retrospective analysis of the clinical activity of fulvestrant in postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer (MBC) previously treated with endocrine therapy and/or chemotherapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Heo, Mi Hwa, Kim, Hee Kyung, Lee, Hansang, Kim, Ji-Yeon, Ahn, Jin-Seok, Im, Young-Hyuck, Park, Yeon Hee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association of Internal Medicine 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6718770/
https://www.ncbi.nlm.nih.gov/pubmed/29540055
http://dx.doi.org/10.3904/kjim.2017.226

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6718770/
https://www.ncbi.nlm.nih.gov/pubmed/29540055
http://dx.doi.org/10.3904/kjim.2017.226

Ejemplares similares